Comparison of relative and attributable risk of myocardial infarction and stroke according to C-reactive protein and low-density lipoprotein cholesterol levels

被引:19
|
作者
Pischon, Tobias
Moehlig, Matthias
Hoffmann, Kurt
Spranger, Joachim
Weikert, Cornelia
Willich, Stefan N.
Pfeiffer, Andreas F. H.
Boeing, Heiner
机构
[1] German Inst Human Nutr DlfE, Dept Epidemiol, Potsdam Rehbruecke, D-14558 Nuthetal, Germany
[2] Charite, Med Ctr, Inst Social Med, Epidemiol & Hlth Econ, Berlin, Germany
[3] German Inst Human Nutr, Dept Clin Nutr, Nuthetal, Germany
[4] Charite Univ Med Ctr, Dept Endocrinol Diabet & Nutr, Berlin, Germany
关键词
competing risk; epidemiology; myocardial infarction; population attributable fraction; risk factors; stroke;
D O I
10.1007/s10654-007-9141-2
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
C-reactive protein (CRP) was proposed as a stronger predictor of cardiovascular events than low-density lipoprotein cholesterol (LDL-C); however, these associations may differ between myocardial infarction (MI) and stroke. We compared statistically the associations of CRP and LDL-C levels with risk of MI versus stroke and examined to what extent consideration of CRP or LDL-C increases the population attributable fractions (PAFs) of MI and stroke beyond traditional risk factors among 27,548 subjects from the European Prospective Investigation into Cancer and Nutrition-Potsdam Study in a case-cohort design. Among subjects without prior MI or stroke, 156 developed MI and 132 stroke during 6.0 years of follow-up. In adjusted competing risk analyses CRP was positively related to MI and stroke (P difference between endpoints = 0.55), whereas LDL-C was related to MI but not stroke (P difference between endpoints = 0.003). The PAF for smoking, diabetes, and hypertension combined was 0.76 for MI, and 0.58 for stroke. With additional consideration of CRP the PAFs were 0.80 and 0.68, while with addition of LDL-C the PAFs were 0.88 and 0.55. We conclude that CRP is equally strongly related to risk of MI and stroke, whereas LDL-C is related to risk of MI but not stroke. Consideration of LDL-C beyond smoking, diabetes and hypertension may increase the PAF of MI slightly more than CRP. In contrast, consideration of CRP but not of LDL-C may increase the PAF of stroke beyond these factors.
引用
收藏
页码:429 / 438
页数:10
相关论文
共 50 条
  • [21] Elevated lipoprotein (a) levels are associated with the acute myocardial infarction in patients with normal low-density lipoprotein cholesterol levels
    Cai, Gaojun
    Huang, Zhiyag
    Zhang, Bifeng
    Yu, Lei
    Li Li, Li
    BIOSCIENCE REPORTS, 2019, 39
  • [22] HIGH AND LOW-DENSITY LIPOPROTEIN CHOLESTEROL IN MYOCARDIAL AND CEREBRAL INFARCTION
    NOMA, A
    MATSUSHITA, S
    KOMORI, T
    ABE, K
    OKABE, H
    KURAMOTO, K
    MURAKAMI, M
    ATHEROSCLEROSIS, 1979, 32 (03) : 327 - 331
  • [23] Elevated C-reactive protein levels in individuals with low high-density lipoprotein cholesterol levels - Reply
    Fredrikson, GN
    Nilsson, J
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2005, 54 (09): : 1267 - 1267
  • [24] Roles of Achieved Levels of Low-Density Lipoprotein Cholesterol and High-Sensitivity C-Reactive Protein on Cardiovascular Outcome in Statin Therapy
    Hyun, Myung Han
    Lee, Yuchang
    Choi, Byoung Geol
    Na, Jin Oh
    Choi, Cheol Ung
    Kim, Jin Won
    Kim, Eung Ju
    Rha, Seung-Woon
    Park, Chang Gyu
    Lee, Eunmi
    Seo, Hong Seog
    CARDIOVASCULAR THERAPEUTICS, 2019, 2019
  • [25] Myocardial Infarction, Stroke, and All-Cause Mortality according to Low-Density Lipoprotein Cholesterol Level in the Elderly, a Nationwide Study
    Lee, You-Bin
    Koo, Minji
    Noh, Eunjin
    Hwang, Soon Young
    Kim, Jung A.
    Roh, Eun
    Hong, So-Hyeon
    Choi, Kyung Mook
    Baik, Sei Hyun
    Cho, Geum Joon
    Yoo, Hye Jin
    DIABETES & METABOLISM JOURNAL, 2022, 46 (05) : 722 - 732
  • [26] Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis
    Dornbrook-Lavender, KA
    Joy, MS
    Denu-Ciocca, CJ
    Chin, H
    Hogan, SL
    Pieper, JA
    PHARMACOTHERAPY, 2005, 25 (03): : 335 - 344
  • [27] Vascular Inflammation Stratified by C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels: Analysis with 18F-FDG PET
    Yoo, Hye Jin
    Kim, Sungeun
    Park, Man Sik
    Yang, Sae Jeong
    Kim, Tae Nyun
    Seo, Ji A.
    Kim, Sin Gon
    Kim, Nan Hee
    Seo, Hong Seog
    Baik, Sei Hyun
    Choi, Dong Seop
    Choi, Kyung Mook
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52 (01) : 10 - 17
  • [28] Ezetimibe added to rosuvastatin for severely hypercholesterolemic patients: Effects on low-density lipoprotein cholesterol and C-reactive protein
    Stein, EA
    Harris, S
    Schleman, M
    Sage, PT
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 392A - 392A
  • [29] Myocardial infarction in young adults with low-density lipoprotein cholesterol levels ≤100 mg/dL
    Akosah, KO
    Cerniglia, RM
    Havlik, P
    Schaper, A
    CHEST, 2001, 120 (06) : 1953 - 1958
  • [30] Effects of individual and integrated cumulative burden of blood pressure, glucose, low-density lipoprotein cholesterol, and C-reactive protein on cardiovascular risk
    Chen, Zimo
    Mo, Jinglin
    Xu, Jie
    Wang, Anxin
    Dai, Liye
    Cheng, Aichun
    Yalkun, Gulbahram
    Meng, Xia
    Zhao, Xingquan
    Li, Hao
    Wu, Shouling
    Wang, Yongjun
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2022, 29 (01) : 127 - 135